| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 08/16/2007 | WO2007076467A3 Use of anecortave acetate as an adjunct during filtration bleb surgery |
| 08/16/2007 | WO2004007437A9 Urea-substituted and urethane-substituted acylureas, methods for the production thereof and their use as medicaments |
| 08/16/2007 | US20070191289 Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs |
| 08/16/2007 | US20070190612 31 Human Secreted Proteins |
| 08/16/2007 | US20070190120 Administration of non-oral androgenic steroids to women |
| 08/16/2007 | US20070190112 Treating neovascularization by placing bioerodible drug delivery system comprising an immunosuppressive agent and a bioerodible polymer (glycolic acid-lactic acid copolymer); sustained release |
| 08/16/2007 | US20070190106 Phosphorus-containing compounds & uses thereof |
| 08/16/2007 | US20070190076 A bacterial preparation consisting of freeze dried, non-denatured Mycobacterium bovis and water, in an amount effective to stimulate leukocytic regulatory cells, used for the prevention and/or the treatment of cancer, autoimmune diseases, allergies and tuberculosis; vaccines |
| 08/16/2007 | CA2635797A1 Stable formulations, and methods of their preparation and use |
| 08/15/2007 | EP1818325A2 3,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 08/15/2007 | EP1818059A1 Preventive or therapeutic agent for glaucoma |
| 08/15/2007 | EP1818008A1 Noninvasive measurements of chemical substances |
| 08/15/2007 | EP1817036A2 Modulators of muscarinic receptors |
| 08/15/2007 | EP1817033A1 Treatment of inflammatory bowel disease |
| 08/15/2007 | EP1817031A1 Novel specific caspase-10 inhibitors |
| 08/15/2007 | EP1496904B1 Use of pharmaceuticals containing n, n'-disubstituted piperazine compounds |
| 08/15/2007 | EP1442023B1 Crystalline sodium salt of telmisartan and the use of the same as an angiotensin antagonist |
| 08/15/2007 | EP1385825B1 Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives |
| 08/15/2007 | EP1353669B1 Method for treating glaucoma |
| 08/15/2007 | EP1343488B1 Treatment of statin side effects |
| 08/15/2007 | EP1339458B1 Combination comprising an agent decreasing vegf activity and an agent decreasing egf activity |
| 08/15/2007 | EP1322596B1 Zwitterionic tachykinin receptor antagonists |
| 08/15/2007 | EP1292568B1 Benzamide ligands for the thyroid receptor |
| 08/15/2007 | CN1331532C Botulinum toxin pharmaceutical compositions |
| 08/15/2007 | CN1331478C Vision acuity improving eye drop and its preparation |
| 08/15/2007 | CN101016296A Muscarinic agonists |
| 08/15/2007 | CN101015628A Chinese medicine for improving eyesight |
| 08/15/2007 | CN101015567A Medicine composition for treating ophthalmological diseases and preparing process thereof |
| 08/15/2007 | CN101015564A Exterior-applied pigmentum for treating otitis media suppurativa and its preparing method |
| 08/15/2007 | CN101015558A Preparation of superfine prednisolone powder |
| 08/15/2007 | CN101015540A Refreshing eyedrop and its preparation |
| 08/14/2007 | US7256217 Prodrugs of excitatory amino acids |
| 08/14/2007 | US7256211 Containing a carboxy-substituted thiazolylthio group, e.g., 15 alpha ,13E)-9-oxo-15-hydroxy-16-(4-fluoro-3-phenylphenyl)-5-(4-carboxythiazol-2-yl)-1,2,3,4,17,18,19,20-octanol-5-thia-8-azaprost-13-ene; EP4 agonistic action and are useful for treating diseases including immunological disorders and asthma |
| 08/14/2007 | US7256205 2-Aminothiazole histamine H2 receptor antagonists such as famotidine or nizatidine to which is linked at least one NO and/or NO2 group; treating inflammations including gastrointestinal disorders and reducing the gastrointestinal toxicity associated with the use of NSAIDS |
| 08/14/2007 | US7256193 Therapeutic agents useful for treating pain |
| 08/14/2007 | US7256183 Administering a nucleotide receptor agonist (such as adenosine triphophate or uridine triphosphate); sinusitis, rhinitis, conjunctivitis, asthma, dermatitis, inflammatory collagen vascular diseases, glomerulonephritis; antiallergens |
| 08/14/2007 | US7256178 Physiologically active substances |
| 08/14/2007 | US7255879 Extracting and recovering embryonic-like stem cells, including pluripotent or multipotent stem cells, from an exsanguinated human placenta; use of the isolated and perfused placenta as a bioreactor in which to propagate endogenous/exogenous cells |
| 08/09/2007 | WO2007089018A1 Triazole derivative |
| 08/09/2007 | WO2007088895A1 3-arylamino-1,2,4-triazole derivative |
| 08/09/2007 | WO2007088783A1 Eye drop/wearing fluid for soft contact lenses |
| 08/09/2007 | WO2007087673A1 Domain antibody construct |
| 08/09/2007 | WO2007058383A3 Lipid secretion promoter containing lacritin or compound having lacritin activity |
| 08/09/2007 | WO2007047744A3 Method for treating primary and secondary forms of glaucoma |
| 08/09/2007 | WO2006042329A8 Crig polypeptide for prevention and treatment of complement-associated disorders |
| 08/09/2007 | US20070185174 Use of thiazole derivatives for preparing a medicament intended to protect the mitochondria |
| 08/09/2007 | US20070185151 Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3 and neuronal nicotinic receptor antagonists |
| 08/09/2007 | US20070185082 Treating rhinitis by topically administering an epinastine solution to the nasal mucous membrane |
| 08/09/2007 | US20070184114 Formulation for topical non-invasive application in vivo |
| 08/09/2007 | US20070184090 PUFA supplements |
| 08/09/2007 | CA2640661A1 Domain antibody construct |
| 08/08/2007 | EP1816138A1 Cyclosporine analogue mixtures and their use as immunomodulating agents |
| 08/08/2007 | EP1816123A1 Intermediates for the production of pharmaceutically active compounds |
| 08/08/2007 | EP1814848A1 2,3,4-substituted-cyclopentanones as therapeutic agents |
| 08/08/2007 | EP1814559A1 Methods and compositions for protecting cells from ultrasound-mediated cytolysis |
| 08/08/2007 | EP1814540A2 Compositions useful to treat ocular neovascular diseases and macular degeneration |
| 08/08/2007 | EP1814535A2 Nitrosated and nitrosylated compounds, compositions and methods for the treatment of ophthalmic disorders |
| 08/08/2007 | EP1814532A2 Topical application of muscarinic and opioid agents for treatment of tinnitus |
| 08/08/2007 | EP1814519A1 Active substance delivery system comprising a hydrogel atrix and microcarriers |
| 08/08/2007 | EP1506202B1 1-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 08/08/2007 | EP0706376B2 Anti-angiogenic compositions and methods of use |
| 08/08/2007 | CN1330649C Carbamate-substituted pyrazolopyridines |
| 08/08/2007 | CN1330371C Recombinant human epidermal growth factor compound biological agent and its use |
| 08/08/2007 | CN1330352C Health care wine and preparation method |
| 08/08/2007 | CN1330293C Fleabane oral disintegration tablet and its preparing process |
| 08/08/2007 | CN101014708A Use of antisense oligonucleotides or sirna to suppress expression of eif-5a1 |
| 08/08/2007 | CN101014332A Agent for treatment of keratoconjunctive disorder |
| 08/08/2007 | CN101014317A Ophthalmic emulsions containing an immunosuppressive agent |
| 08/08/2007 | CN101011569A Method for diagnosing and treating type II dentinogenesis by using DSPP gene and encoding product thereof |
| 08/08/2007 | CN101011536A Nose-ear health care traditional Chinese medicine preparation and stifling warm-wet therapy |
| 08/08/2007 | CN101011489A Cordate houttuynia eye drops and its preparation method |
| 08/08/2007 | CN101011458A Traditional Chinese medicine formulation for treating ulcer |
| 08/08/2007 | CN101011407A Amphotericin B liposome antigungal eye drops and its preparation method |
| 08/08/2007 | CN101011388A Chewing tablet with vision fatigue relieving function |
| 08/08/2007 | CN101011375A Combretastatin A-4 eye-using preparation for treating diabetic retinopathy |
| 08/08/2007 | CN101011361A Dispersible tablet of bendazac lysine and its preparation method |
| 08/08/2007 | CN101011151A Health care bamboo salt and its preparing method |
| 08/07/2007 | US7253294 Saponifying green plant oleoresin to provide a saponified resin, adding a first volatile organic solvent to provide a suspension, removing the solids, condensing the solution to provide an oil; and adding a second volatile organic solvent to solidify the natural product |
| 08/07/2007 | US7253286 Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective |
| 08/07/2007 | US7253199 Azole derivatives and pharmaceutical compositions containing them |
| 08/07/2007 | US7253174 (Anilino)(halo)pyrimidine derivatives or (anilino)(amino)pyrimidine derivatives; treating rheumatoid arthritis, psoriasis, Crohn's Disease, osteoarthritis or osteoporosis. |
| 08/07/2007 | US7253172 Enzyme inhibitor for treating a non-insulin dependent diabetes mellitus; 3-Amino-4-(3,4-difluorophenyl)butanoyl]-4-[2-({3-[(methylsulfonyl)amino]-phenyl}-amino)-2-oxoethyl]piperazin-2-yl}acetic acid |
| 08/07/2007 | US7253171 Antiinflammatory agents; immunology diseases; multiple sclerosis; antihistamines; antidiabetic agents; vision defects; antiarthritic agents; skin disorders; antitumor agents |
| 08/07/2007 | CA2376379C Modified chimeric polypeptides with improved pharmacokinetic properties |
| 08/07/2007 | CA2340636C Combinations of tetracyclic cyclic gmp-specific phosphodiesterase inhibitors with further therapeutic agents |
| 08/07/2007 | CA2324887C Ophthalmic composition comprising a .beta.-blocker |
| 08/07/2007 | CA2207804C Amides of mono and bicarboxylic acids with amino acids or glycosamines, selectively active on the cannabinoid peripheral receptor |
| 08/02/2007 | WO2007086584A1 NOVEL INHIBITOR OF FabK AND FabI/K |
| 08/02/2007 | WO2007086490A1 Remedy for disease associated with choroidal angiogenesis |
| 08/02/2007 | WO2007086044A1 Adenosine a3 receptor agonists for the treatment of dry eye disorders |
| 08/02/2007 | WO2007085652A1 Use of the (s) enantiomer of mequitazine for preparing a medicament, while at the same time limiting genomic toxicity |
| 08/02/2007 | WO2007085203A1 New substituted pentabasic azaheterocyclic compounds and its use of treating protein aging disease |
| 08/02/2007 | WO2007047874A3 Recombinantly modified plasmin |
| 08/02/2007 | US20070179297 Chemical compounds |
| 08/02/2007 | US20070179150 Nitrosated proton pump inhibitors, compositions and methods of use |
| 08/02/2007 | US20070179087 Method for treating inflammatory diseases using heat shock proteins |
| 08/02/2007 | CA2637917A1 Therapeutic agents for diseases involving choroidal neovascularization |
| 08/01/2007 | EP1813618A1 Method of obtaining derivatives of 4-(n-alkylamine)-5,6-dihydro-4h-thieno-[2,3-b]-thiopyran |
| 08/01/2007 | EP1813286A2 Pharmaceutical composition containing a compound having angiotensin II antagonistic activity in combination with another compound |
| 08/01/2007 | EP1813269A1 TRANSCRIPTIONAL FACTOR Nrf2 ACTIVATOR AND FOOD HAVING THE FUNCTION OF THE SAME IMPARTED THERETO |